Current problems associated with conventional cancer chemotherapies include insolubility of drugs in aqueous medium; delivery of sub-therapeutic doses to target cells; lack of bioavailability; and ...

Back in September 2004, the US National Cancer Institute (NCI) launched the Alliance for Nanotechnology in Cancer to stimulate and coordinate research in biology, engineering and materials science ...

The third program, still in development, is a next-generation vaccine developed against COVID ... between a nanotechnology research team at Kyoto University and a cancer immunology team based ...

Professor Yu, from UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN), said a new solution was needed because TNBC cancer cells lacked the proteins targeted by some of the ...

"Despite the promise of immunotherapy, its effectiveness against triple-negative breast cancer is extremely limited ... not only for TNBC but also for other hard-to-treat cancers like ovarian cancer.

University of Queensland researchers are designing nanotechnology ... was needed because TNBC cancer cells lacked the proteins targeted by some of the treatments used against other cancers.

The Department of Science and Technology (DOST) Industrial Technology Development Institute developed a nanotechnology that can detect bacteria, viruses, and even cancer cells. Featured by Martin ...

(Image: Canva) Scientists at the University of Queensland (UQ) are pioneering a new nanotechnology approach that could revolutionise treatment for the most aggressive form of breast cancer.

The following is a summary of "Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer ...